Nature Conference: Innovative Tissue Therapies from Bench to Bedside

Register for #NatconfTissue21, organized by Nature Communications, to hear from an international panel of speakers as they share their latest advancements in tissue engineering, gene therapy, cell therapy, and innovative clinical treatments.
Nature Conference: Innovative Tissue Therapies from Bench to Bedside
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

At an upcoming virtual Nature Conference, Innovative Tissue Therapies from Bench to Bedside, we will hear from scientists developing innovative pre-clinical approaches in the realm of gene therapy, cell therapy and tissue engineering. Similarly, clinical researchers will give their perspective on the application of the most promising innovative treatments in human patients. 

Event Details 
November 16-18, 2021
07:00 EST (New York) | 12:00 GMT (London) | 13:00 CST (Milan) | 20:00 CST (Shanghai)

Presented by: I.R.C.C.S Ospedale San Raffaele and Nature Communications

Register now and be sure to submit your abstract by the September 20th deadline!

Learn more

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Follow the Topic

Biotechnology
Life Sciences > Biological Sciences > Biotechnology

Related Collections

With collections, you can get published faster and increase your visibility.

Advances in catalytic hydrogen evolution

This collection encourages submissions related to hydrogen evolution catalysis, particularly where hydrogen gas is the primary product. This is a cross-journal partnership between the Energy Materials team at Nature Communications with Communications Chemistry, Communications Engineering, Communications Materials, and Scientific Reports. We seek studies covering a range of perspectives including materials design & development, catalytic performance, or underlying mechanistic understanding. Other works focused on potential applications and large-scale demonstration of hydrogen evolution are also welcome.

Publishing Model: Open Access

Deadline: Sep 30, 2024

Cancer epigenetics

With this cross-journal Collection, the editors at Nature Communications, Communications Biology, Communications Medicine, and Scientific Reports invite submissions covering the breadth of research carried out in the field of cancer epigenetics. We will highlight studies aiming at the improvement of our understanding of the epigenetic mechanisms underlying cancer initiation, progression, response to therapy, metastasis and tumour plasticity as well as findings that have the potential to be translated into the clinic.

Publishing Model: Open Access

Deadline: Oct 31, 2024